This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ziporen, L. Articles by Shoenfeld, Y. Search for Related Content PubMed PubMed Citation Articles by Ziporen, L. Articles by Shoenfeld, Y. Social Bookmarking                         What's this?

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

Research Unit of Autoimmune Diseases and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel

I. Goldberg

Department of Pathology, Sheba Medical Center, Tel-Hashomer, Israel

M. Arad

Departments of Internal Medicine and Pathology, Beilinson Hospital, Petach Tikva

M. Hojnik

Research Unit of Autoimmune Diseases and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel

J. Ordi-Ros

internal Medicine 3° Planta, Vall D'Hebron, Barcelona, Spain

A. Afek

Department of Pathology, Sheba Medical Center, Tel-Hashomer, Israel

M. Blank

Research Unit of Autoimmune Diseases and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel

Y. Sandbank

Departments of Internal Medicine and Pathology, Beilinson Hospital, Petach Tikva

M. Vilardell-Tarres

internal Medicine 3° Planta, Vall D'Hebron, Barcelona, Spain

I. de Torres

internal Medicine 3° Planta, Vall D'Hebron, Barcelona, Spain

A. Weinberger

Departments of Internal Medicine and Pathology, Beilinson Hospital, Petach Tikva

RA Asherson

Rheumatic Diseases Unit, Department of Medicine, University of Capetown, School of Medicine, Capetown, South Africa

Y. Kopolovic

Department of Pathology, Sheba Medical Center, Tel-Hashomer, Israel

Y. Shoenfeld

Research Unit of Autoimmune Diseases and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel

Objective. To examine the potential immunologic mechanism and involvement of antiphos pholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphos pholipid syndrome (APS).

Methods. Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derived from eight patients with the APS, either primary or secondary to systemic lupus erythematosus. Primary antibodies to human immuno globulins, complement components, serum albumin and a monoclonal anti-idiotypic anti body to human anticardiolipin antibodies (aCL) were employed. Various tissue specimens from a patient with the APS as well as deformed and normal valves from subjects without the APS were used as controls.

Results. Linear subendothelial deposition consisting of immunoglobulins with complement components but not of a non-specific serum protein was found in deformed valves from patients with the APS. None of the control valves or tissues disclosed similar deposition. The same pattern and location of staining was obtained by the anti-idiotypic antibody to aCL. A significant amount of IgG immunoglobulins that bound to cardiolipin was eluted from a valve of a patient with secondary APS.

Conclusion. Deposits of immunoglobulins including aCL, and of complement components, are common in affected valves of patients with primary and secondary APS. Such deposits may be involved in the pathogenesis of valvular lesions.

Key Words: heart valves • Libman-Sacks endocarditis • antiphospholipid syndrome • anti cardiolipin antibodies • systemic lupus erythematosus

Lupus, Vol. 5, No. 3, 196-205 (1996)
DOI: 10.1177/096120339600500306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. A. Binstadt, J. L. Hebert, A. Ortiz-Lopez, R. Bronson, C. Benoist, and D. Mathis The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms PNAS, September 29, 2009; 106(39): 16758 - 16763. [Abstract] [Full Text] [PDF]

				D Jain and M K Halushka Cardiac pathology of systemic lupus erythematosus J. Clin. Pathol., July 1, 2009; 62(7): 584 - 592. [Abstract] [Full Text] [PDF]

				Z Rotar, B Rozman, P. de Groot, M Sanmarco, Y Shoenfeld, P. Meroni, R Cervera, V Pengo, R Cimaz, T Avcin, et al. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus, January 1, 2009; 18(1): 53 - 60. [Abstract] [PDF]

				M Rottem, I Krause, A Fraser, L Stojanovich, J Rovensky, and Y Shoenfeld Autoimmune Hemolytic Anaemia in the Antiphospholipid Syndrome Lupus, July 1, 2006; 15(7): 473 - 477. [Abstract] [PDF]

				M. Blank, I. Krause, L. Magrini, G. Spina, J. Kalil, S. Jacobsen, H. J. Thiesen, M. W. Cunningham, L. Guilherme, and Y. Shoenfeld Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome Rheumatology, July 1, 2006; 45(7): 833 - 841. [Abstract] [Full Text] [PDF]

				Y Shoenfeld, M Blank, R Cervera, J Font, E Raschi, and P-L Meroni Infectious origin of the antiphospholipid syndrome Ann Rheum Dis, January 1, 2006; 65(1): 2 - 6. [Full Text] [PDF]

				I Krause, S Lev, A Fraser, M Blank, M Lorber, L Stojanovich, J Rovensky, J Chapman, and Y Shoenfeld Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome Ann Rheum Dis, October 1, 2005; 64(10): 1490 - 1493. [Abstract] [Full Text] [PDF]

				A Tincani, C Biasini-Rebaioli, R Cattaneo, and P Riboldi Nonorgan specific autoantibodies and heart damage Lupus, September 1, 2005; 14(9): 656 - 659. [Abstract] [PDF]

				F Tenedios, D Erkan, and M D Lockshin Cardiac involvement in the antiphospholipid syndrome Lupus, September 1, 2005; 14(9): 691 - 696. [Abstract] [PDF]

				M Blank, A Aron-Maor, and Y Shoenfeld From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus, September 1, 2005; 14(9): 697 - 701. [Abstract] [PDF]

				M Lockshin, F Tenedios, M Petri, G McCarty, R Forastiero, S Krilis, A Tincani, D Erkan, M A Khamashta, and Y Shoenfeld Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report Lupus, July 1, 2003; 12(7): 518 - 523. [Abstract] [PDF]

				H. G. Bulckaen, F. L. Puisieux, E. D. Bulckaen, C. Di Pompeo, O. M. Bouillanne, A. A. Watel, A.-L. M. Fauchais, P. De Groote, and A. Millaire Antiphospholipid Antibodies and the Risk of Thromboembolic Events in Valvular Heart Disease Mayo Clin. Proc., March 1, 2003; 78(3): 294 - 298. [Abstract] [PDF]

				M Bijl, J Brouwer, and G G. Kallenberg Grand Rounds from International Lupus Centres Cardiac abnormalities in SLE: pancarditis Lupus, May 1, 2000; 9(4): 236 - 240. [Abstract] [PDF]

				A Afek, Y Shoenfeld, R Manor, I Goldberg, L Ziporen, J George, S Polak-Charcon, M C Amigo, R Garcia-Torres, R Segal, et al. Increased endothelial cell expression of a3{beta}1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome Lupus, September 1, 1999; 8(7): 502 - 507. [Abstract] [PDF]

				Y. Shoenfeld and L. Ziporen Review : Lessons from experimental APS models Lupus, January 1, 1998; 7(2_suppl): S158 - S161. [Abstract] [PDF]